Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4741 AL 4755

Amyloid-beta Targeted Therapeutic Approaches for Alzheimer's Disease: Long Road Ahead

Dai Y, Lei C, Zhang Z, Qi Y, Lao K, Gou X.

Curr Drug Targets. 2022;23(11):1040-1056. doi: 10.2174/1389450123666220421124030.

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease

Aillaud I, Funke SA.

Cell Mol Neurobiol. 2023 Apr;43(3):951-961. doi: 10.1007/s10571-022-01230-7. Epub 2022 May 21.

Healthcare Costs Associated with Potentially Inappropriate Medication Prescribing Detected by Computer Algorithm Among Older Patients

Pagès A, Costa N, Mounié M, Cestac P, De Souto Barreto P, Rolland Y, Vellas B, Molinier L, Juillard-Condat B; MAPT/DSA Group.

Drugs Aging. 2022 May;39(5):367-375. doi: 10.1007/s40266-022-00938-x. Epub 2022 May 24.

Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope

Nabi SU, Khan A, Siddiqui EM, Rehman MU, Alshahrani S, Arafah A, Mehan S, Alsaffar RM, Alexiou A, Shen B.

Oxid Med Cell Longev. 2022 May 14;2022:4759963. doi: 10.1155/2022/4759963. eCollection 2022.

Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease

Zhao W, Liu Y, Xu L, He Y, Cai Z, Yu J, Zhang W, Xing C, Zhuang C, Qu Z.

ACS Chem Neurosci. 2022 Jun 15;13(12):1697-1713. doi: 10.1021/acschemneuro.2c00172. Epub 2022 May 23.

Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease

Benussi A, Cantoni V, Grassi M, Brechet L, Michel CM, Datta A, Thomas C, Gazzina S, Cotelli MS, Bianchi M, Premi E, Gadola Y, Cotelli M, Pengo M, Perrone F, Scolaro M, Archetti S, Solje E, Padovani A, Pascual-Leone A, Borroni B.

Ann Neurol. 2022 Aug;92(2):322-334. doi: 10.1002/ana.26411. Epub 2022 Jun 6.

Latest progress in the development of multitarget ligands for Alzheimer's disease based on the Hantzsch reaction

Ismaili L, Bernard PJ, Refouvelet B.

Future Med Chem. 2022 Jul;14(13):943-946. doi: 10.4155/fmc-2022-0080. Epub 2022 May 24.

APP processing: a biochemical competition influenced by exercise-induced signaling mediators?

Marko DM, MacPherson REK.

Am J Physiol Regul Integr Comp Physiol. 2022 Aug 1;323(2):R169-R180. doi: 10.1152/ajpregu.00297.2021. Epub 2022 May 24.

Genetic Architecture of Primary Tauopathies

Gallo D, Ruiz A, Sánchez-Juan P.

Neuroscience. 2023 May 10;518:27-37. doi: 10.1016/j.neuroscience.2022.05.022. Epub 2022 May 21.

Role of Aducanumab in the Treatment of Alzheimer's Disease: Challenges and Opportunities

Vaz M, Silva V, Monteiro C, Silvestre S.

Clin Interv Aging. 2022 May 18;17:797-810. doi: 10.2147/CIA.S325026. eCollection 2022.

Mouse models of Alzheimer's disease for preclinical research

Watamura N, Sato K, Saido TC.

Neurochem Int. 2022 Sep;158:105361. doi: 10.1016/j.neuint.2022.105361. Epub 2022 May 23.

Revealing cell vulnerability in Alzheimer's disease by single-cell transcriptomics

Saura CA, Deprada A, Capilla-López MD, Parra-Damas A.

Semin Cell Dev Biol. 2023 Apr;139:73-83. doi: 10.1016/j.semcdb.2022.05.007. Epub 2022 May 24.

Transgenic Mouse Models of Alzheimer's Disease: An Integrative Analysis

Sanchez-Varo R, Mejias-Ortega M, Fernandez-Valenzuela JJ, Nuñez-Diaz C, Caceres-Palomo L, Vegas-Gomez L, Sanchez-Mejias E, Trujillo-Estrada L, Garcia-Leon JA, Moreno-Gonzalez I, Vizuete M, Vitorica J, Baglietto-Vargas D, Gutierrez A.

Int J Mol Sci. 2022 May 12;23(10):5404. doi: 10.3390/ijms23105404.

Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients

Tuzimski T, Petruczynik A.

Molecules. 2022 May 18;27(10):3222. doi: 10.3390/molecules27103222.

Diet Patterns, the Gut Microbiome, and Alzheimer's Disease

Fairley A, Stewart CJ, Cassidy A, Woodside JV, McEvoy CT.

J Alzheimers Dis. 2022;88(3):933-941. doi: 10.3233/JAD-220205.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias